Skip To Main Content
David Ziegler on Muck Rack

David Ziegler

As seen in: Nature, The Washington Post, USA Today, Fortune, MDPI, The Conversation, The Indiegogo Review, NJ.com, The Epoch Times, Yahoo and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with David

Contact David, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Family experiences of receiving treatment recommendations in a precision medicine trial for poor-prognosis childhood cancer

|
By Kate Hetherington, Jacqueline Hunter, Mark Donoghoe, Maeve McGillycuddy, Brittany C. McGill, Eden G. Robertson, Vanessa J Tyrrell, Loretta Lau, Katherine Tucker, Glenn Marshall, Janine Vetsch, Michelle Haber, David Malkin, Marion Mateos, Tracey A. O’Brien, David Ziegler, Claire E. Wakefield, Jonathon M. Marron
| Nature Verified
Abstract Precision medicine trials may generate new treatment options for children with poor-prognosis cancer. We examined families’ experiences of receiving treatment recommendations in the Australian PRISM trial (Australian and New Zealand Clinical Trials Registry: NCT03336931; https://clinicaltrials.gov/study/NCT03336931; registration date 08/11/2017).
Open in Who Shared Issue with article?

Retired ATF agent warns of federal enforcement tactics in N.J. | Opinion Original

|
By David Ziegler
| NJ.com Verified
I warned about immigration enforcement policies in 2020, when they were playing out in places like Portland. It felt distant then. It isn’t anymore — the same tactics have arrived here, and so are the consequences. After 28 years as a federal special agent, my career and service were a source of pride, and I always felt a strong sense that those in the role were respected for their responsibilities.
Open in Who Shared View Duplicates (2) Issue with article?

Precision-guided therapy in H3K27-altered diffuse midline glioma

|
By Chelsea Mayoh, Phoebe Power, Sophie Jessop, Jordan Staunton, Sarah Trinder, Nataliya Zhukova, Cristina Mignone, Frank Alvaro, Peter Downie, Jordan Hansford, Santosh Valvi, Marion Mateos, Paulette Barahona, Andrew Gifford, Gabor Tax, Maria Tsoli, Emmy Dolman, Marie Wong, Mark Cowley, Glenn Marshall, Toby Trahair, Paul Ekert, Michelle Haber, Loretta Lau, Neevika Manoharan, David Ziegler, Dong-Anh Khuong-Quang, Campbell J. L. McKay, Shampavi Sriharan, Dinisha Govender, Tim Hassall, Vanessa Tyrell
| Nature Verified
Abstract Precision-guided therapy (PGT) approaches have shown improved survival in children with high-risk cancer, but it is unclear whether children with H3K27-altered diffuse midline glioma (DMG) benefit from this approach.
Open in Who Shared Issue with article?
See all 60 licensed articles (67 Total)